Tagatose 6-phosphate epimerase mutants and their use in increasing conversion of d-tagatose

CN122941652APending Publication Date: 2026-10-20SHANDONG XINGGUANG CAPITAL BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611310515.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-27
Publication Date
2026-10-20

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure SMS_1
    Figure SMS_1
Patent Text Reader

Abstract

This invention discloses a tagatose 6-phosphate epimerase mutant and its application in improving D-tagatose conversion, belonging to the fields of genetic engineering and enzyme engineering technology. The tagatose 6-phosphate epimerase mutant disclosed in this invention exhibits the following mutations based on the amino acid sequence shown in SEQ ID NO.9: N139I-Q192W, Q192W, or N139I. The optimal mutant TPE3 produces a final tagatose concentration of 120.6 g / L, with a relative mass conversion rate of 80.4% to maltodextrin. This invention utilizes a multi-enzyme catalytic route to prepare tagatose, offering advantages such as high substrate utilization, low cost, and high tagatose yield, making it suitable for large-scale tagatose production.
Need to check novelty before this filing date? Find Prior Art